{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:31Z","timestamp":1786994011357,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mcpro.2022.100416","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T01:38:53Z","timestamp":1663810733000},"page":"100416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-6767","authenticated-orcid":false,"given":"Carine","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-8738","authenticated-orcid":false,"given":"Pierre","family":"Lescuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Tille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-8520","authenticated-orcid":false,"given":"Axel","family":"Ducret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2022.100416_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcdb.2016.08.026","article-title":"Cancer heterogeneity determined by functional proteomics","volume":"64","author":"Szasz","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mcpro.2022.100416_bib2","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.3748\/wjg.v22.i26.5896","article-title":"Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: a review of the literature","volume":"22","author":"Matboli","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mcpro.2022.100416_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.eururo.2016.08.024","article-title":"The emergence of precision urologic oncology: a collaborative review on biomarker-driven therapeutics","volume":"71","author":"Barbieri","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mcpro.2022.100416_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrc2113","article-title":"Shaping the future of biomarker research in breast cancer to ensure clinical relevance","volume":"7","author":"Hinestrosa","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2016.12.005","article-title":"Strategies to design clinical studies to identify predictive biomarkers in cancer research","volume":"53","author":"Perez-Gracia","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mcpro.2022.100416_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/002215549804600314","article-title":"Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections","volume":"46","author":"Ikeda","year":"1998","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.mcpro.2022.100416_bib7","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1002\/pmic.200600016","article-title":"Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within","volume":"6","author":"Hood","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.clinbiochem.2012.10.002","article-title":"The proteomics of formalin-fixed wax-embedded tissue","volume":"46","author":"Vincenti","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mcpro.2022.100416_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/epr.13.3","article-title":"Proteomic studies of formalin-fixed paraffin-embedded tissues","volume":"10","author":"Giusti","year":"2013","journal-title":"Exp. Rev. Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2015.09.002","article-title":"High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy","volume":"10","author":"Nuciforo","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100586","article-title":"Absolute quantitation of met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue","volume":"9","author":"Catenacci","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2022.100416_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jmoldx.2013.03.002","article-title":"Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue","volume":"15","author":"Hembrough","year":"2013","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.mcpro.2022.100416_bib13","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1074\/mcp.O115.049049","article-title":"Quantification of HER2 by targeted mass spectrometry in formalin-fixed paraffin-embedded (FFPE) breast cancer tissues","volume":"14","author":"Steiner","year":"2015","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s10120-015-0566-0","article-title":"Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH","volume":"19","author":"Catenacci","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib15","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mcpro.2022.100416_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: a critical review","volume":"52","author":"Reis-Filho","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.mcpro.2022.100416_bib17","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib18","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","article-title":"Molecular classification and molecular forecasting of breast cancer: ready for clinical application?","volume":"23","author":"Brenton","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib19","first-page":"73","article-title":"Established breast cancer risk factors and risk of intrinsic tumor subtypes","volume":"1856","author":"Barnard","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcpro.2022.100416_bib20","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.mcpro.2022.100416_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000433622","article-title":"Targeted therapies in triple-negative breast cancer","volume":"10","author":"Marme","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.mcpro.2022.100416_bib22","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.2147\/DDDT.S86105","article-title":"The role of taxanes in triple-negative breast cancer: literature review","volume":"9","author":"Mustacchi","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.mcpro.2022.100416_bib23","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.breast.2015.07.009","article-title":"Clinical implications of molecular heterogeneity in triple negative breast cancer","volume":"24","author":"Lehmann","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.mcpro.2022.100416_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2022.100416_bib25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib26","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2022.100416_bib27","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jclinpath-2012-201361","article-title":"Therapeutic targets in triple negative breast cancer","volume":"66","author":"O'Toole","year":"2013","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib29","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/bcr3035","article-title":"A\u00a0clinically relevant gene signature in triple negative and basal-like breast cancer","volume":"13","author":"Rody","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib30","doi-asserted-by":"crossref","first-page":"djt376","DOI":"10.1093\/jnci\/djt376","article-title":"Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer","volume":"106","author":"Liu","year":"2014","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.mcpro.2022.100416_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-9164-8_13","article-title":"Development of a highly multiplexed SRM assay for biomarker discovery in formalin-fixed paraffin-embedded tissues","volume":"1959","author":"Steiner","year":"2019","journal-title":"Met. Mol. Biol."},{"key":"10.1016\/j.mcpro.2022.100416_bib32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1021\/ac701680f","article-title":"Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides","volume":"80","author":"Scherl","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2022.100416_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pmic.201100463","article-title":"Using iRT, a normalized retention time for more targeted measurement of peptides","volume":"12","author":"Escher","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/pmic.201100533","article-title":"Highly multiplexed targeted proteomics using precise control of peptide retention time","volume":"12","author":"Gallien","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib35","first-page":"1","article-title":"Rapid assay development and refinement for targeted protein quantitation using an intelligent SRM (iSRM) workflow","volume":"468","author":"Kiyonami","year":"2009","journal-title":"Thermo Sci. Appl. Note"},{"key":"10.1016\/j.mcpro.2022.100416_bib36","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1021\/ac102179j","article-title":"Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry","volume":"82","author":"Maclean","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2022.100416_bib37","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1021\/pr5006636","article-title":"Panorama: a targeted proteomics knowledge base","volume":"13","author":"Sharma","year":"2014","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/prca.201400150","article-title":"Characterization of a human pluripotent stem cell-derived model of neuronal development using multiplexed targeted proteomics","volume":"9","author":"Dunkley","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.mcpro.2022.100416_bib39","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib40","first-page":"1609","article-title":"A\u00a0perspective on anti-EGFR therapies targeting triple-negative breast cancer","volume":"6","author":"Nakai","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3747\/co.v18i4.824","article-title":"Triple-negative and basal-like breast cancer: implications for oncologists","volume":"18","author":"Lachapelle","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13058-019-1118-z","article-title":"Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the breast international group trial 1-98","volume":"21","author":"Kensler","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41591-021-01242-8","article-title":"Androgen receptor agonists as breast cancer therapeutics","volume":"27","author":"Caswell-Jin","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2022.100416_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/humrep\/dev279","article-title":"Postovulatory aging affects dynamics of mRNA, expression and localization of maternal effect proteins, spindle integrity and pericentromeric proteins in mouse oocytes","volume":"31","author":"Trapphoff","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mcpro.2022.100416_bib45","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1021\/pr300130t","article-title":"Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue","volume":"11","author":"Sprung","year":"2012","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib46","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1039\/c1mb05113j","article-title":"Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches","volume":"7","author":"Gamez-Pozo","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.mcpro.2022.100416_bib47","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1021\/acs.jproteome.9b00490","article-title":"Parallel reaction monitoring-mass spectrometry (PRM-MS)-Based targeted proteomic surrogates for intrinsic subtypes in breast cancer: comparative analysis with immunohistochemical phenotypes","volume":"19","author":"Park","year":"2020","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2022.100416_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange","year":"2008","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mcpro.2022.100416_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jms.1895","article-title":"Selected reaction monitoring applied to proteomics","volume":"46","author":"Gallien","year":"2011","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.mcpro.2022.100416_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000430499","article-title":"Role of the tumor microenvironment in breast cancer","volume":"82","author":"Soysal","year":"2015","journal-title":"Pathobiology"},{"key":"10.1016\/j.mcpro.2022.100416_bib52","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/j.1460-2075.1994.tb06386.x","article-title":"The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer","volume":"13","author":"Stein","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.mcpro.2022.100416_bib53","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1074\/jbc.272.13.8490","article-title":"Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7","volume":"272","author":"Janes","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2022.100416_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12026-018-8987-6","article-title":"The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages","volume":"66","author":"Ihedioha","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: from TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mcpro.2022.100416_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbcan.2017.11.004","article-title":"Long pentraxin 3: a novel multifaceted player in cancer","volume":"1869","author":"Giacomini","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/0008-5472.CAN-20-1976","article-title":"Chemotherapy-induced upregulation of small extracellular vesicle-associated PTX3 accelerates breast cancer metastasis","volume":"81","author":"Wills","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib58","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1038\/s41467-020-16051-9","article-title":"SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2022.100416_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.18632\/genesandcancer.147","article-title":"Identification of candidate genes associated with triple negative breast cancer","volume":"8","author":"Player","year":"2017","journal-title":"Genes Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib60","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1007\/s13277-015-4361-7","article-title":"Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers","volume":"37","author":"Scimeca","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mcpro.2022.100416_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jclinpath-2016-203786","article-title":"Expression of proliferation genes in formalin-fixed paraffin-embedded (FFPE) tissue from breast carcinomas. Feasibility and relevance for a routine histopathology laboratory","volume":"70","author":"Thomas","year":"2017","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib62","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.8290962","article-title":"Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells","volume":"263","author":"Zou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2022.100416_bib63","first-page":"5681","article-title":"Maspin suppresses the invasive phenotype of human breast carcinoma","volume":"58","author":"Seftor","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib64","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jcb.25969","article-title":"The opportunity of precision medicine for breast cancer with context-sensitive tumor suppressor maspin","volume":"118","author":"Bernardo","year":"2017","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.mcpro.2022.100416_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ijc.10500","article-title":"Expression of maspin predicts poor prognosis in breast-cancer patients","volume":"100","author":"Umekita","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2559.2003.01620.x","article-title":"Expression of maspin is up-regulated during the progression of mammary ductal carcinoma","volume":"42","author":"Umekita","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.mcpro.2022.100416_bib67","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.humpath.2009.02.006","article-title":"High expression of maspin is associated with early tumor relapse in breast cancer","volume":"40","author":"Joensuu","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2559.2003.01567.x","article-title":"Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer","volume":"42","author":"Kim","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.mcpro.2022.100416_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1746-1596-6-36","article-title":"Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer","volume":"6","author":"Umekita","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib70","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ajpath.2011.10.020","article-title":"TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer","volume":"180","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib71","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-13-3579","article-title":"TRIM29 suppresses TWIST1 and invasive breast cancer behavior","volume":"74","author":"Ai","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib72","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-18-1495","article-title":"Loss of TRIM29 alters keratin distribution to promote cell invasion in squamous cell carcinoma","volume":"78","author":"Yanagi","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091805","article-title":"Tissue specific DNA methylation in normal human breast epithelium and in breast cancer","volume":"9","author":"Avraham","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2022.100416_bib74","doi-asserted-by":"crossref","first-page":"22231","DOI":"10.1073\/pnas.1015245107","article-title":"Inositol polyphosphate 4-phosphatase II regulates PI3K\/Akt signaling and is lost in human basal-like breast cancers","volume":"107","author":"Fedele","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2022.100416_bib75","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/2159-8290.CD-19-1262","article-title":"The INPP4B tumor suppressor modulates EGFR trafficking and promotes triple-negative breast cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcpro.2022.100416_bib76","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13058-014-0406-x","article-title":"PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors","volume":"16","author":"Lehmann","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib77","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/modpathol.2013.97","article-title":"A\u00a0survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard","volume":"26","author":"Won","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4048\/jbc.2020.23.e11","article-title":"Analysis of tau protein expression in predicting pathological complete response to neoadjuvant chemotherapy in different molecular subtypes of breast cancer","volume":"23","author":"Lei","year":"2020","journal-title":"J.\u00a0Breast Cancer"},{"key":"10.1016\/j.mcpro.2022.100416_bib79","first-page":"5179","article-title":"Predictive and prognostic value of the TauProtein in breast cancer","volume":"35","author":"Bonneau","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib80","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0046-8177(95)90146-9","article-title":"Prognostic significance of MUC1 epithelial mucin expression in breast cancer","volume":"26","author":"McGuckin","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib81","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800445","article-title":"Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer","volume":"18","author":"Rakha","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib82","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2559.2007.02757.x","article-title":"The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma","volume":"51","author":"van der Vegt","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.mcpro.2022.100416_bib83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cas.12596","article-title":"Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes","volume":"106","author":"Iizuka","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mcpro.2022.100416_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","article-title":"PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3beta\/beta-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer","volume":"36","author":"Gao","year":"2017","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2022.100416_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10585-019-10000-7","article-title":"Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer","volume":"37","author":"Metcalf","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.mcpro.2022.100416_bib86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2559.1987.tb02688.x","article-title":"Correlation between immunohistochemically determined oestrogen receptor content, using monoclonal antibodies, and qualitative and quantitative tissue features in ductal breast cancer","volume":"11","author":"Tosi","year":"1987","journal-title":"Histopathology"},{"key":"10.1016\/j.mcpro.2022.100416_bib87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/path.1711510410","article-title":"Clinicopathological significance of intratumoural variations in elastosis grades and the oestrogen receptor status of human breast carcinomas","volume":"151","author":"Giri","year":"1987","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.mcpro.2022.100416_bib88","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1044-579X(02)00027-5","article-title":"Extracellular matrix components in breast carcinomas","volume":"12","author":"Kadar","year":"2002","journal-title":"Semin. Cancer Biol."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947622002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947622002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:09:57Z","timestamp":1761527397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947622002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1535947622002249"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2022.100416","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2022.100416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100416"}}